Dr Olly Donnelly
PhD FRCR MRCP BSc (Hons)
Some of the principal treatments carried out by Dr Olly Donnelly at Spire include:
Immunotherapy - treatment with checkpoint inhibitors such as ipilimumab and pembrolizumab.
MBChB / University of Bristol / 2002
Bachelor of medicine, Bachelor of surgery
PhD / University of Leeds / 2013
FRCR / Royal Colleges / 2013
Royal College of Radiologists
MRCP / Royal Colleges / 2007
Membership of the Royal Colleges of Physicians of the United Kingdom
Consultant Oncologist, University Hospital Southampton.
Honorary Senior Lecturer, University of Southampton.